The National AIDS Treatment Advocacy Project - NATAP - provides the latest in HIV and AIDS drug development and treatment information (on topics including protease inhibitors, nucleosides, non-nucleosides, double protease combinations), as well as comprehensive reports and developments from the Fifth Retroviruses and Opportunistic Infections conference, as well as from the ICAR, ICAAC, IDSA, European and International HIV and AIDS conferences.